美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Golden Eagle Dynamic Hypergrowth ETF

25.55

+0.26001.03%

成交量：294.00

成交額：7,554.61

市值：2,887.15萬

市盈率：- -

高：25.55

開：25.55

低：25.55

收：25.29

52周最高：28.67

52周最低：21.06

股本：113.00萬

流通股本：113.00萬

量比：0.03

換手率：0.03%

股息：0.03

股息率：0.13%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

麻吉今晚持續加倉 ETH 和 HYPE 多單，新多頭倉位價值已近 500 萬美元

數據：麻吉加倉 HYPE 和 ETH 多單，目前浮盈 20 萬美元

匯宇製藥(688553.SH)：HYP-6589片聯合用藥獲得藥物臨床試驗申請受理

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/HYP/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HYP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HYP\",,,,,undefined,":{"symbol":"HYP","market":"US","secType":"STK","nameCN":"Golden Eagle Dynamic Hypergrowth ETF","latestPrice":25.55,"timestamp":1774453055840,"preClose":25.29,"halted":0,"volume":294,"delay":0,"changeRate":0.010280743376828848,"floatShares":1130000,"shares":1130000,"eps":0,"marketStatus":"交易中","change":0.26,"latestTime":"03-25 11:39:40 EDT","open":25.55,"high":25.55,"low":25.55,"amount":7554.606948,"amplitude":0,"askPrice":25.83,"askSize":100,"bidPrice":25.76,"bidSize":1900,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774468800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":25.29,"sharesOutstanding":1050000,"nav":24.9896,"aum":28238209.45,"dividendRate":0.001288,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.29,"preClose":25.29,"latestTime":"16:10 EDT","volume":7,"amount":177.03,"timestamp":1774383004139,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.032697},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HYP\",,,,,undefined,":{"symbol":"HYP","floatShares":1130000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.032697,"shares":1130000,"dividePrice":0.0329,"high":25.55,"amplitude":0,"preClose":25.29,"low":25.55,"week52Low":21.06,"pbRate":"--","week52High":28.67,"institutionHeld":0,"latestPrice":25.55,"committee":0.9,"eps":0,"divideRate":0.001288,"volume":294,"delay":0,"ttmEps":0,"open":25.55,"prevYearClose":23.4566,"prevWeekClose":24.32,"prevMonthClose":27.4133,"prevQuarterClose":23.4566,"fiveDayClose":25.45,"twentyDayClose":27.9479,"sixtyDayClose":24.2657},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HYP\",params:#limit:5,,,undefined,":[{"date":"2025-12-24","symbol":"HYP","amount":0.031908,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Golden Eagle Dynamic Hypergrowth ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HYP\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-24","recordDate":"2025-12-24","paymentDate":"2025-12-26","value":0.031908,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HYP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HYP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607047553","title":"麻吉今晚持續加倉 ETH 和 HYPE 多單，新多頭倉位價值已近 500 萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607047553","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607047553?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 23:37","pubTimestamp":1769787426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7607433","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["ETH.USD.CC","HYP","BK4601"],"gpt_icon":0},{"id":"2606736778","title":"數據：麻吉加倉 HYPE 和 ETH 多單，目前浮盈 20 萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606736778","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606736778?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 23:45","pubTimestamp":1769528705,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 Hyperinsight 监测，麻吉加仓 HYPE 和 ETH 多单，其累计持有价值超 1,182 万美元 ETH 和 HYPE 多单，浮盈 20 万美元。其中：· 持有 3,000 枚 ETH 多单（876 万美元）；· 持有 109,888.88 枚 HYPE 多单（304 万美元）。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2240927","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETH.USD.CC","HYP","BK4601"],"gpt_icon":0},{"id":"2585155681","title":"匯宇製藥(688553.SH)：HYP-6589片聯合用藥獲得藥物臨床試驗申請受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2585155681","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585155681?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 17:00","pubTimestamp":1763715628,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汇宇制药 发布公告，公司全资子公司四川汇宇海玥医药科技有限公司于2025年11月21日收到国家药品监督管理局核准签发的《受理通知书》，HYP-6589片用于开展与奥希替尼联合治疗靶点驱动基因阳性的晚期非小细胞肺癌的临床试验申请获得受理。HYP-6589片是公司全资子公司汇宇海玥开发的高选择性SOS1小分子抑制剂，其注册分类为化学药1类创新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688553","HYP","BK0239"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}